These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3733408)
21. [Probucol in the treatment of hypercholesterolemia]. da Cunha GP; da Cunha CL Arq Bras Cardiol; 1981 Jul; 37(1):63-6. PubMed ID: 7348171 [No Abstract] [Full Text] [Related]
22. Experience with probucol in the treatment of hypercholesterolemia. Davignon J; Lussier-Cacan S; Dubreuil-Quidoz S; LeLorier J Artery; 1982; 10(1):48-55. PubMed ID: 7092576 [No Abstract] [Full Text] [Related]
23. Correlative design of electrophoretic and ultracentrifugal investigation of metabolic effects of probucol. Opplt JJ; Chick LL; Opplt MA Artery; 1982; 10(2):131-49. PubMed ID: 7092580 [TBL] [Abstract][Full Text] [Related]
24. Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas. Wissler RW; Vesselinovitch D Appl Pathol; 1983; 1(2):89-96. PubMed ID: 6678159 [TBL] [Abstract][Full Text] [Related]
25. Probucol: a weak hypocholesterolemic agent. Mishkel MA; Crowther SM Can Med Assoc J; 1981 Jul; 125(2):135. PubMed ID: 7272863 [No Abstract] [Full Text] [Related]
26. Usefulness of probucol in treating primary hypercholesterolemia. Enjalbert M; Lussier-Cacan S; DuBreuil-Quidoz S; LeLorier J; Davignon J Can Med Assoc J; 1980 Oct; 123(8):754-7. PubMed ID: 7448680 [TBL] [Abstract][Full Text] [Related]
27. Treatment of hyperlipidemia with probucol reduces proteinuria in puromycin aminonucleoside-induced nephrotic rats. Hirano T; Mamo JC; Ohnami K; Sugisaki T Nephron; 1990; 54(4):358-9. PubMed ID: 2325806 [No Abstract] [Full Text] [Related]
28. Treatment of hyperlipoproteinemias with neomycin, probucol and tibric acid. Miettinen TA Adv Exp Med Biol; 1977; 82():483-8. PubMed ID: 920404 [No Abstract] [Full Text] [Related]
29. Effect of probucol on bile composition in man. Jirsa M; Marecek Z; Kerdac V; Kucerova L Artery; 1982; 10(1):44-7. PubMed ID: 7092575 [No Abstract] [Full Text] [Related]
30. [Clinical assessment of probucol and its therapeutical effect on hypercholesterolaemia (author's transl)]. Herdová J; Zapletalová J Cas Lek Cesk; 1981 Jul; 120(27):832-5. PubMed ID: 7261004 [No Abstract] [Full Text] [Related]
31. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia]. Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746 [No Abstract] [Full Text] [Related]
32. [Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia]. Pasquali R; Melchionda N; Parenti M; Cavazzini MG; Biso P; Baraldi G; Sorrenti G; De Benedittis G; Labò G Clin Ter; 1982 Dec; 103(5):509-20. PubMed ID: 7160143 [No Abstract] [Full Text] [Related]
33. Long-term administration of probucol and QTc interval prolongation. Sasaki N; Saku K; Moroe K; Zhang B; Hirata K; Liu R; Arakawa K Artery; 1993; 20(2):115-21. PubMed ID: 8512458 [TBL] [Abstract][Full Text] [Related]
34. The long-term effects of probucol on serum lipid levels. McCaughan D Arch Intern Med; 1981 Oct; 141(11):1428-32. PubMed ID: 7025778 [TBL] [Abstract][Full Text] [Related]
35. [Action of the new hypocholesteremic agent DH-581 (dithiobisphenol) in humans]. Brusco OJ; Oriozabala MA; Arakaki R Prensa Med Argent; 1971 Oct; 58(32):1587-94. PubMed ID: 4943247 [No Abstract] [Full Text] [Related]
36. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol]. Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586 [No Abstract] [Full Text] [Related]
37. [Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)]. Beaumont JL; Jacotot B; Buxtorf JC; Meliço-Silvestre AA; Beaumont V Nouv Presse Med; 1980 Oct; 9(40):2995-3000. PubMed ID: 7443438 [TBL] [Abstract][Full Text] [Related]
38. Nine years of treatment with probucol. McCaughan D Artery; 1982; 10(1):56-70. PubMed ID: 6807262 [No Abstract] [Full Text] [Related]